INS and polycystic ovary syndrome: However, one-way ANOVA analysis assessing changes within the control or the PCOS groups during the time course showed that intralipid and a combination of intralipid and insulin suppressed FGF19 in control (P < 0.01) and in the PCOS groups (P < 0.0001).